A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.
Not Applicable
- Conditions
- Advanced or recurrent lung cancer
- Registration Number
- JPRN-UMIN000053550
- Lead Sponsor
- iigata University Medical and Dental Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 165
Inclusion Criteria
Not provided
Exclusion Criteria
(1) FDG uptake on lung region was difficult to evaluate owing to massive consolidation or pleural effusion (2) Patients with bilateral multiple primary lung cancers.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interstitial lung disease after administration of immune checkpoint inhibitors
- Secondary Outcome Measures
Name Time Method Prognosis after administration of immune checkpoint inhibitors